NCT03987191View on ClinicalTrials.gov

Insulin Pump to Multiple Daily Injection Transition Clinical Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

January 10, 2020

Primary Completion Date

October 8, 2020

Study Completion Date

October 8, 2020

Conditions
Type 1 Diabetes
Interventions
DRUG

Multiple daily ijnection using Insulin Degludec and Insulin Aspart

Drug: Insulin Degludec and insulin Aspart Pharmaceutical form: Solution for injection Route of administration: Subcutaneous

Trial Locations (1)

80045

Barbara Davis Center for Diabetes, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT03987191 - Insulin Pump to Multiple Daily Injection Transition Clinical Trial | Biotech Hunter | Biotech Hunter